MedTrace Logo

A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

NCT01966328 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-03-31

No results posted yet for this study

Summary

This research is studying the effect that Resolvine injection will have on patients with vitreomacular adhesion.

Conditions

  • Vitreomacular Attachment
  • Vitreomacular Traction
  • Vitreomacular Adhesion

Interventions

DRUG

36% Resolvine Intravitreal Injection

36% Resolvine Intravitreal Injection

DRUG

9% Resolvine Intravitreal Injection

9% Resolvine Intravitreal Injection

Sponsors & Collaborators

  • Kato Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Jeffrey S Heier

    lead OTHER

Principal Investigators

  • Jeffrey S Heier, MD · Ophthalmic Consultants of Boston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01966328 on ClinicalTrials.gov